ALL ALS Consortium enrolls 1,000th participant
January 20, 2026
The Access for All in ALS (ALL ALS) Consortium has announced enrollment of its 1,000th participant, marking a major milestone for what is designed to be
Tenga en cuenta que el contenido de esta página solo está disponible en inglés. Lamentamos cualquier inconveniente que esto pueda causar.
The Access for All in ALS (ALL ALS) Consortium has announced enrollment of its 1,000th participant, marking a major milestone for what is designed to be
Missed our recent webinar? The recording is now available! Learn how to access and navigate the largest open ALS data platform, designed to accelerate research and
North Bethesda, MD, September 11, 2025—The Foundation for the National Institutes of Health (FNIH) announces the launch of a dedicated research portal for the Accelerating Medicines
ALL ALS Consortium Launches Website to Advance ALS Research The Access for All in ALS (ALL ALS) Consortium announced the launch of its official website,
Recent progress in therapeutics for amyotrophic lateral sclerosis (ALS) has spurred development and imbued the field of ALS with hope for more breakthroughs, yet substantial
The Access for All in ALS Consortium (ALL ALS) announced the successful enrollment of the first participant. Established in the autumn of 2023 with funding
El Consorcio ALL ALS y todos los estudios relacionados son financiados por los Institutos Nacionales de Salud (NIH), Subvención N.º 1OT2NS136938 y 1OT2NS136939.